国际中医中药杂志
國際中醫中藥雜誌
국제중의중약잡지
INTERNATIONAL JOURNAL OF TRIDITIONAL CHINESE MEDICINE
2015年
2期
109-113
,共5页
洪兰%李桂侠%刁倩%王亚娜%汪卫东
洪蘭%李桂俠%刁倩%王亞娜%汪衛東
홍란%리계협%조천%왕아나%왕위동
失眠症%睡眠调控技术%低阻抗意念导入疗法%佐匹克隆片
失眠癥%睡眠調控技術%低阻抗意唸導入療法%佐匹剋隆片
실면증%수면조공기술%저조항의념도입요법%좌필극륭편
Insomnia%Sleep-regulating technique%thought imprint psychotherapy under lower resistant state%Zopiclone
目的：评价低阻抗睡眠调控技术（thought imprint psychotherapy under lower resistant state, TIP3-2）对失眠症的治疗效果。方法收集2011年1月－2013年6月在广安门医院心理科就诊的失眠症患者120例，采用密闭信封法由第3方利用SAS 软件给出种子数，将患者随机分为治疗组（90例）和对照组（30例）。治疗组和对照组分别采用TIP3-2和佐匹克隆治疗4周。利用匹兹堡睡眠质量指数（PSQI）量表、多导睡眠监测（PSG）、自制睡眠信心量表对该技术的疗效进行评价。结果治疗组和对照组分别有79例和28例完成治疗。PSQI评分显示，治疗组睡眠质量[(1.3±0.65)分比(1.8±0.50)分；t＝6.378,P＝0.000]、日间功能[(1.5±0.89)分比(2.1±0.66)分；t＝13.624,P＝0.000]和总分[(9.6±3.35)分比(12.4±2.83)分；t＝22.124,P＝0.000]均较对照组显著改善。PSG检查显示，治疗组觉醒次数[(3.4±2.49)次比(4.2±4.02)次；t＝4.196,P＝0.043]、1期睡眠时间[(35.0±19.42)%比(43.0±23.31)%；t＝4.593,P＝0.034]、2期睡眠时间[(40.3±16.47)%比(34.9±16.57)%；t＝4.255,P＝0.042]差异有统计学意义。治疗组睡眠信心量表总分较对照组显著改善[（8.6±5.85）分比（12.8±3.84）分；t＝11.346，P＝0.001]。结论 TIP3-2可提高睡眠信心，对失眠症有确切疗效，且优于佐匹克隆。
目的：評價低阻抗睡眠調控技術（thought imprint psychotherapy under lower resistant state, TIP3-2）對失眠癥的治療效果。方法收集2011年1月－2013年6月在廣安門醫院心理科就診的失眠癥患者120例，採用密閉信封法由第3方利用SAS 軟件給齣種子數，將患者隨機分為治療組（90例）和對照組（30例）。治療組和對照組分彆採用TIP3-2和佐匹剋隆治療4週。利用匹玆堡睡眠質量指數（PSQI）量錶、多導睡眠鑑測（PSG）、自製睡眠信心量錶對該技術的療效進行評價。結果治療組和對照組分彆有79例和28例完成治療。PSQI評分顯示，治療組睡眠質量[(1.3±0.65)分比(1.8±0.50)分；t＝6.378,P＝0.000]、日間功能[(1.5±0.89)分比(2.1±0.66)分；t＝13.624,P＝0.000]和總分[(9.6±3.35)分比(12.4±2.83)分；t＝22.124,P＝0.000]均較對照組顯著改善。PSG檢查顯示，治療組覺醒次數[(3.4±2.49)次比(4.2±4.02)次；t＝4.196,P＝0.043]、1期睡眠時間[(35.0±19.42)%比(43.0±23.31)%；t＝4.593,P＝0.034]、2期睡眠時間[(40.3±16.47)%比(34.9±16.57)%；t＝4.255,P＝0.042]差異有統計學意義。治療組睡眠信心量錶總分較對照組顯著改善[（8.6±5.85）分比（12.8±3.84）分；t＝11.346，P＝0.001]。結論 TIP3-2可提高睡眠信心，對失眠癥有確切療效，且優于佐匹剋隆。
목적：평개저조항수면조공기술（thought imprint psychotherapy under lower resistant state, TIP3-2）대실면증적치료효과。방법수집2011년1월－2013년6월재엄안문의원심이과취진적실면증환자120례，채용밀폐신봉법유제3방이용SAS 연건급출충자수，장환자수궤분위치료조（90례）화대조조（30례）。치료조화대조조분별채용TIP3-2화좌필극륭치료4주。이용필자보수면질량지수（PSQI）량표、다도수면감측（PSG）、자제수면신심량표대해기술적료효진행평개。결과치료조화대조조분별유79례화28례완성치료。PSQI평분현시，치료조수면질량[(1.3±0.65)분비(1.8±0.50)분；t＝6.378,P＝0.000]、일간공능[(1.5±0.89)분비(2.1±0.66)분；t＝13.624,P＝0.000]화총분[(9.6±3.35)분비(12.4±2.83)분；t＝22.124,P＝0.000]균교대조조현저개선。PSG검사현시，치료조각성차수[(3.4±2.49)차비(4.2±4.02)차；t＝4.196,P＝0.043]、1기수면시간[(35.0±19.42)%비(43.0±23.31)%；t＝4.593,P＝0.034]、2기수면시간[(40.3±16.47)%비(34.9±16.57)%；t＝4.255,P＝0.042]차이유통계학의의。치료조수면신심량표총분교대조조현저개선[（8.6±5.85）분비（12.8±3.84）분；t＝11.346，P＝0.001]。결론 TIP3-2가제고수면신심，대실면증유학절료효，차우우좌필극륭。
Objective To evaluate the efficacy of sleep-regulating technique of low resistance thought imprint psychotherapy (TIP3-2) for insomnia. Methods A total of 120 patients with insomnia were enrolled and randomly allocated to either a treatment group (60 patients) or a control group (30 patients). The patients in the treatment group and the control group were treated by TIP3-2 and zopiclone for 4 weeks, respectively. The therapeutic effect was evaluated using the Pittsburgh Sleep Quality Index (PSQI), polysomnography and the self-made sleep confidence scale. Results A total of 79 patients in the treatment group and 28 patients in the control group completed treatment. PSQI scores showed that overall sleep quality (1.3 ± 0.65 vs. 1.8 ± 0.50;t=6.378, P=0.000), daytime function (1.5 ± 0.89 vs. 2.1 ± 0.66;t=13.624, P=0.000) and total score (9.6 ± 3.35 vs. 12.4 ± 2.83;t=22.124, P=0.000) in the treatment group were significantly improved compared with the control group. Polysomnography showed significant difference between two groups in the times of awakening (3.4 ± 2.49 vs. 4.2 ± 4.02;t=4.196, P=0.043), and the percentages of sleep stages 1 and 2 (stage 1:35.0%± 19.42%vs. 43.0%± 23.31%, t=4.593, P=0.034;stage 2:40.3%± 16.47%vs. 34.9%± 16.57%, t=4.255, P=0.042). The total score of the sleep confidence scale in the treatment group showed a significantly improvement compared with the control group (8.6 ± 5.85 vs. 12.8 ± 3.84, t=11.346, P=0.001). Conclusion TIP3-2 can improve sleep confidence, have certain efficacy for insomnia, and may be superior to zopiclone.
